Myriad falls on patent ruling; sector indices slip
March 30, 2010 at 10:39 AM EDT
Myriad Genetics fall in early action after a U.S. federal court rules against the company in a dispute involving seven of its gene-analysis patents.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.